Endogenous mineralization, inclusions, and deposition disorders

Dail and Hammar's Pulmonary Pathology

Volumn 1, Issue , 2008, Pages 760-806

  Farver, Carol F ^a   Dail, David H ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79954524466     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-68792-6_21     Document Type: Chapter

References (346)

1. Wilks S. Ossific deposits on larynx, trachea and bronchi. Trans Pathol Soc (Lond) 1857;8:88.
2. Nienhuis DM, Prakash UB, Edell ES. Tracheobronchopathia osteochondroplastica. Ann Otol Rhinol Laryngol 1990;99:689-694.
3. Aschoff-Freiburg L. Uber Tracheopathia osteoplastica. Verh Dtsch Pathol Ges 1910;14:125-127.
4. Prakash UB, McCullough AE, Edell ES, et a1. Tracheopathia osteoplastic a: familial occurrence. Mayo Clin Proc 1989;64(9):1091-1096.
5. Prakash UB. Tracheobronchopathia Osteochondroplastica. Semin Respir Crit Care Med 2002;23:67-75.
6. Dalgaard JB. Tracheopathia chondro-osteoplastica: a case elucidating the problems concerning development and ossification of elastic cartilage. Acta Pathol Microbiol Scand 1947;24:18-34.
7. Martin CJ. Tracheobronchopathia osteochondroplastica. Arch Otolaryngo 11974;100(4):290-293.
8. Eimind K. Tracheopathia chondro-osteoplastica. Nord Med 1964;72:1029-1031.
9. Jepsen 0, Sorensen H. Tracheopathia osteoplastica and ozaena. Acta OtolaryngoI1960;51:79-83.
10. Sen RP, Walsh TE. Fiberoptic bronchoscopy for refractory cough. Chest 1991;99:33-35.
11. Restrepo S, Pandit M, Villamil MA, et a1. Tracheobronchopathia osteochondroplastica: helical CT findings in 4 cases. J Thorac Imaging 2004;19:112-116.
12. Carr DT, Olsen AM. Tracheopathia osteoplastica. JAMA 1954;155:1563-1565.
13. Harma RA, Suurkari S. Tracheopathia chondro-osteoplastica. A clinical study of thirty cases. Acta Otolaryngol1977;84: 118-123.
14. Hodges MK, Israel E. Tracheobronchopathia osteochondroplastica presenting as right middle lobe collapse. Diagnosis by bronchoscopy and computerized tomography. Chest 1988;94:842-844.
15. Pounder DJ, Pieterse AS. Tracheopathia osteoplastica: a study of the minimal lesion. J Pathol 1982;138:235-239.
16. Tajima K, Yamakawa M, Katagiri T, et a1. Immunohistochemical detection of bone morphogenetic protein-2 and transforming growth factor beta-1 in tracheopathia osteochondroplastica. Virchows Arch 1997;431:359-363.
17. Alroy GG, Lichtig C, Kaftori JK. Tracheobronchopathia osteoplastica: end stage of primary lung amyloidosis? Chest 1972;61:465-468.
18. Sakula A. Tracheobronchopathia osteoplastica: its relationship to primary tracheobronchial amyloidosis. Thorax 1968;23:105-110.
19. Shuttleworth JS, Self CL, Pershing HS. Tracheopathia osteoplastica. Ann Intern Med 1960;52:234-242.
20. Hui AN, Koss MN, Hochholzer L, et a1. Amyloidosis presenting in the lower respiratory tract. Clinicopathologic, radiologic, immunohistochemical, and histochemical studies on 48 cases. Arch Pathol Lab Med 1986;110: 212-218.
21. Baugnee PE, Delaunois LM. Mycobacterium avium-intracellulare associated with tracheobronchopathia osteochondroplastica. Eur Respir J 1995;8:180-182.
22. Kocyildirim E, Kanani M, Roebuck D, et a1. Long-segment tracheal stenosis: slide tracheoplasty and a multidisciplinary approach improve outcomes and reduce costs. J Thorac Cardiovasc Surg 2004;128:876-882.
23. Shin JH, Song HY, Shim TS. Management of tracheobronchial strictures. Cardiovasc Intervent Radiol 2004;27: 314-324.
24. Urbach E, Wiethe C. Lipoidosis cutis et mucosae. Arch Pathol Anat 1929;273:285-219.
25. Caplan RM. Visceral involvement in lipoid proteinosis. Arch Dermatol 1967;95:149-155.
26. Acar A, Eryilmaz A, Gocer C, et a1. Lipoid proteinosis of larynx: review of four cases. Int J Pediatr Otorhinolaryngol 2004;68:1557-1561.
27. Moscovic EA. Sarcoidosis and mycobacterial L-forms. A critical reappraisal of pleomorphic chromogenic bodies (Hamazaki corpuscles) in lymph nodes. Pathol Annu 1978;13:69-164.
28. Carstens PH, Kuhns JG, Ghazi C. Primary malignant melanomas of the lung and adrenal. Hum Pathol 1984;15: 910-914.
29. Salm R. A primary malignant melanoma of the bronchus. J Pathol BacterioI1963;85:121-126.
30. Allen MS Jr, Drash EC. Primary melanoma of the lung. Cancer 1968;21:154-159.
31. Rocken C, Sletten K. Amyloid in surgical pathology. Virch Arch 2003;443:3-16:
32. Hirschfield GM. Amyloidosis: a clinico-pathophysiological synopsis. Semin Cell Dev Bioi 2004;15:39-44.
33. Chen KT. Amyloidosis presenting in the respiratory tract. Pathol Annu 1989;24:253-273.
34. Falk RH, Skinner M. The systemic amyloidoses: an overview. Adv Intern Med 2000;45:107-137.
35. Gertz MA, Kyle RA. Primary systemic amyloidosis-a diagnostic primer. Mayo Clin Proc 1989;64:1505-1519.
36. Kaplan B, Martin BM, Livneh A, et a1. Biochemical sUbtyping of amyloid in formalin-fixed tissue samples confirms and supplements immunohistologic data. Am J Clin Pathol 2004;121:794-800.
37. Rocken C, Sletten K. Amyloid in surgical pathology. Virchows Arch 2003;443:3-16.
38. Glenner GG. Amyloid deposits and amyloidosis. The betafibrilloses (first of two parts). N Engl J Med 1980;302: 1283-1292.
39. Page DL, Isersky C, Harada M, et al. Immunoglobulin origin of localized nodular pulmonary amyloidosis. Res Exp Med (Berlin) 1972;159:75-86.
40. Wright JR, Calkins E, Humphrey RL. Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease. Lab Invest 1977;36:274-281.
41. van Rijswijk MH, van Heusden Cw. The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice. Am J PathoI1979;97:43-58.
42. Cordier JF, Loire R, Brune J. Amyloidosis of the lower respiratory tract. Clinical and pathologic features in a series of 21 patients. Chest 1986;90:827-831.
43. Gertz MA, Greipp PRo Clinical aspects of pulmonary amyloidosis. Chest 1986;90:790-791.
44. Cohen AS. Amyloidosis (concluded). N Engl J Med 1967;277:628-638.
45. Klatskin G. Nonspecific green birefringence in Congo redstained tissues. Am J PathoI1969;56:1-13.
46. Toriumi 1. The lung in generalized amyloidosis. Acta Pathol Jpn 1972;22:141-152.
47. Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine (Baltimore) 1975;54:271-299.
48. Serpell LC, Sunde M, Blake Cc. The molecular basis of amyloidosis. Cell Mol Life Sci 1997;53:871-887.
49. Linke RP. Highly sensitive diagnosis of amyloid and various amyloid syndromes using congo red fluorescence. Virch Arch 2000;436:439-448.
50. Reiman HA, Koucky RF, Ecklung CM. Primary amyloidosis limited to tissue of mesodermal origin. Am J Pathol 1935;11:977-988.
51. Isobe T, Osserman EF. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins. N Engl J Med 1974;290:473-477.
52. Duff GL. Primary systemic sarcoidosis: a diagnostic primer. Am J Med Sci 1954;328:317-333.
53. Dahlin DC. Primary amyloidosis, with report of six cases. Am J PathoI1949;25:105-123.
54. Smith RR, Hutchins GM, Moore GW, et al. 1Ype and distribution of pulmonary parenchymal and vascular amyloid. Correlation with cardiac amyloid. Am J Med 1979;66: 96-104.
55. Celli BR, Rubinow A, Cohen AS, et al. Patterns of pulmonary involvement in systemic amyloidosis. Chest 1978;74: 543-547.
56. Utz JP, Swensen SJ, Gertz MA. Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993. Ann Intern Med 1996;124:407-413.
57. Kuhlback B, Wegelius 0. Secondary amyloidosis: a study, of clinical and pathological findings. Acta Med Scand 1966;180:737-745.
58. McGlennen RC, Burke BA, Dehner LP. Systemic amyloidosis complicating cystic fibrosis. A retrospective pathologic study. Arch Pathol Lab Med 1986;110:879-884.
59. Munoz-Bonet 11, Ibarra I, Perez-Navero JL, et al. Secondary amyloidosis detected in a patient with cystic fibrosis after undergoing lung transplantation. Transplantation 2002;73:1173-1174.
60. Stokes MB, Jagirdar J, Burchstin 0, et al. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient. Mod PathoI1997;1O:1059-1065.
61. Shah SP, Khine M, Anigbogu J, et al. Nodular amyloidosis of the lung from intravenous drug abuse: an uncommon cause of multiple pulmonary nodules. South Med J 1998;91:402-404.
62. Jayalakshmi P, Looi LM, Lim KJ, et al. Autopsy findings in 35 cases of leprosy in Malaysia. Int J Lepr Other Mycobact Dis 1987;55:510-514.
63. Pitkanen P, Westermark P, Cornwell GG, III. Senile systemic amyloidosis. Am J PathoI1984;117:391-399.
64. Laden SA, Cohen ML, Harley RA. Nodular pulmonary amyloidosis with extrapulmonary involvement. Hum Pathol 1984;15:594-597.
65. Monreal FA. Pulmonary amyloidosis: ultrastructural study of early alveolar septal deposits. Hum Pathol 1984;15: 388-390.
66. Rubinow A, Celli BR, Cohen AS, et al. Localized amyloidosis of the lower respiratory tract. Am Rev Respir Dis 1978;118:603-611.
67. Gillmore JD, Hawkins PN. Amyloidosis and the respiratory tract. Thorax 1999;54:444-451.
68. Thompson PJ, Citron KM. Amyloid and the lower respiratory tract. Thorax 1983;38:84-87.
69. Thompson PJ, Jewkes J, Corrin B, et al. Primary bronchopulmonary amyloid tumour with massive hilar lymphadenopathy. Thorax 1983;38:153-154.
70. Lesser A. Ein Fall von Enchondroma osteiodes mixtum der Lunge mit partieller Amyloidentartung. Virchows Arch Pathol Anat 1877;69:404-408.
71. Prowse CB. Amyloidosis of the lower respiratory tract. Thorax 1958;13:308-320.
72. Balser W. Tracheo und Bronchialstenose mit Amyloid in der Wandungen der Leftwege. Virchows Arch Pathol Anat 1883;91:67-76.
73. Dood AR, Mann JD. Primary diffuse amyloidosis of the respiratory tract. AMA Arch PathoI1959;67:39-42.
74. Gottlieb LS, Gold WM. Primary tracheobronchial amyloidosis. Am Rev Respir Dis 1972;105:425-429.
75. O'Regan A, Fenlon HM, Beamis JF Jr, et al. Tracheobronchial amyloidosis. The Boston University experience from 1984 to 1999. Medicine (Baltimore) 2000;79:69-79.
76. Strange C, Heffner JE, Collins BS, et al. Pulmonary hemorrhage and air embolism complicating transbronchial biopsy in pulmonary amyloidosis. Chest 1987;92:367-369.
77. Road JD, Jacques J, Sparling JR. Diffuse alveolar septal amyloidosis presenting with recurrent hemoptysis and medial dissection of pulmonary arteries. Am Rev Respir Dis 1985;132:1368-1370.
78. Revol L, Mournier-Kuhn P, Paliard Petal. L'amyloidose primitive de l'abre tracheobronchique a propos d'un nouveau cas. Rev Med Lyon 1965;14:583-585.
79. Jones AW, Chatterji AN. Primary tracheobronchial amyloidosis with tracheobronchopathia osteoplastica. Br J Dis Chest 1977;71:268-272.
80. Rejou 11, Bannier M. Amylose bronchique primitive et tracheopathie chondreosteoplastique. Quest Med 1978;31: 197-201.
81. Loire R, Saugier J, Brune J, et al. Amylose et tracheobronchopathie osteoplastique a propose de trois observations. Lyon Med 1978;239:75-78.
82. Lee SC, Johnson H. Multiple nodular pulmonary amyloidosis. A case report and comparison with diffuse alveolar-septal pulmonary amyloidosis. Thorax 1975;30: 178-185.
83. Desai RA, Mahajan VK, Benjamin S, et al. Pulmonary amyloidoma and hilar adenopathy. Rare manifestations of primary amyloidosis. Chest 1979;76:170-173.
84. Firestone FN, Joison 1. Amyloidosis. A cause of primary tumors of the lung. J Thorac Cardiovasc Surg 1966;51: 292-299.
85. Saab SB, Burke J, Hopeman A, et al. Primary pulmonary amyloidosis. Report of two cases. J Thorac Cardiovasc Surg 1974;67:301-307.
86. Becker BJP. Tumour-forming amyloidosis of the lung. Med Proc 1961;7:107-109.
87. Fenoglio C, Pascal RR. Nodular amyloidosis of the lungs. An unusual case associated with chronic lung disease and carcinoma of the bladder. Arch Pathol 1970;90:577-582.
88. Ikeda S, Takabayashi Y, Maejima Y, et al. Nodular lung disease with five year survival and unilateral pleural effusion in AL amyloidosis. Amyloid 1999;6:292-296.
89. Battaglia S, Masini T. Paramilodosi neoplastiforme del polmone. Folia Hered PathoI1957;6:69-127.
90. Weiss L. Isolated multiple nodular pulmonary amyloidosis. Am J Clin PathoI1960;33:318-329.
91. Himmelfarb E, Wells S, Rabinowitz JG. The radiologic spectrum of cardiopulmonary amyloidosis. Chest 1977;72: 327-332.
92. Eisenberg R, Sharma OP. Primary pulmonary amyloidosis. An unusual case with 14 years' survival. Chest 1986;89: 889-891.
93. Kobayashi H, Matsuoka R, Kitamura S, et al. Sjogren's syndrome with multiple bullae and pulmonary nodular amyloidosis. Chest 1988;94:438-440.
94. Bonner H Jr, Ennis RS, Geelhoed GW, et al. Lymphoid infiltration and amyloidosis of lung in Sjogren's syndrome. Arch Pathol 1973;95:42-44.
95. Davis CJ, Butchart EG, Gibbs AR. Nodular pulmonary amyloidosis occurring in association with pulmonary lymphoma. Thorax 1991;46:217-218.
96. Dacic S, Colby TV, Yousem SA. Nodular amyloidoma and primary pulmonary lymphoma with amyloid production: a differential diagnostic problem. Mod Pathol 2000;13: 934-940.
97. Lim JK, Lacy MQ, Kurtin PJ, et al. Pulmonary marginal zone lymphoma of MALT type as a cause of localised pulmonary amyloidosis. J Clin Pathol 2001;54:642-646.
98. Brown I Primary Amyloidosis. Clin Radiol 1964;15: 358-367.
99. Dirkse PRo Primary amyloidosis of the lungs. Am J Roentgenol Radium Ther Nucl Med 1946;56:577-585.
100. Garcia GF, Calleja Canelas JL. Letter: hilar enlargement in amyloidosis. N Engl J Med 1974;291:53l.
101. Ito M, Sugiyama E, Akagawa N, et al. Immunological studies on an unusual case of primary pulmonary amyloidosis with hilar adenopathy. Jpn J Med 1982;21:216-222.
102. Kidd CR, Fred HL, Natelson EA. Letter: Bilateral hilar adenopathy in amyloidosis. N Engl J Med 1974;290:972.
103. Shaw P, Grossman R, Fernandes BI Nodular mediastinal amyloidosis. Hum PathoI1984;15:1183-1185.
104. Melato M, Antonutto G, Falconieri G, et al. Massive amyloidosis of mediastinal lymph nodes in a patient with multiple myeloma. Thorax 1983;38:151-152.
105. Hsiu JG, Stitik FP, D'Amato NA, et al. Primary amyloidosis presenting as a unilateral hilar mass. Report of a case diagnosed by fine needle aspiration biopsy. Acta Cytol 1986;30:55-58.
106. Kanada DJ, Sharma OP. Long-term survival with diffuse interstitial pulmonary amyloidosis. Am J Med 1979;67: 879-882.
107. Shiue ST, McNally DP. Pulmonary hypertension from prominent vascular involvement in diffuse amyloidosis. Arch Intern Med 1988;148:687-689.
108. Dingli D, Vtz JP, Gertz MA. Pulmonary hypertension in patients with amyloidosis. Chest 2001;120:1735-1738.
109. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises; case 48-1977. N Engl J Med 1977;297:1221-1228.
110. Lundin P, Simonsson B, Winberg T. Pneumonopleural amyloid tumour. Report of a case. Acta Radiol 1961;55: 139-144.
111. Vilaseca J, Cuevas J, Fresno M, et al. Systemic amyloidosis in cystic fibrosis. Am J Dis Child 1981;135:667.
112. Graham DR, Ahmad D. Clinical aspects of pulmonary amyloidosis. Chest 1987;92:576-577.
113. Knapp MJ, Roggli VL, Kim J, et al. Pleural amyloidosis. Arch Pathol Lab Med 1988;112:57-60.
114. Kavuru MS, Adamo JP, Ahmad M, et al. Amyloidosis and pleural disease. Chest 1990;98:20-23.
115. Gonzalez-Cueto DM, Rigoli M, Gioseffi LM, et al. Diffuse pulmonary amyloidosis. Am J Med 1970;48:668-670.
116. Poh SC, Tjia TS, Seah He. Primary diffuse alveolar septal amyloidosis. Thorax 1975;30:186-191.
117. Rajan VT, Kikkawa Y. Alveolar septal amyloidosis in primary amyloidosis. An electron microscopic study. Arch PathoI1970;89:521-525.
118. Ohdama S, Akagawa S, Matsubara 0, et al. Primary diffuse alveolar septal amyloidosis with multiple cysts and calcification. Eur Respir J 1996;9:1569-1571.
119. Kijner CH, Yousem SA. Systemic light chain deposition disease presenting as multiple pulmonary nodules. A case report and review of the literature. Am J Surg Patho11988;12: 405-413.
120. Seymour AE, Thompson AJ, Smith PS, et al. Kappa light chain glomerulosclerosis in multiple myeloma. Am J Pathol 1980;101:557-580.
121. Cohen 11, Colvin RB. Case records of the Massachusetts General Hospital. N Engl J Med 1981;304:33-43.
122. Silver MM, Hearn SA, Ritchie S, et al. Renal and systemic kappa light chain deposits and their plasma cell origin identified by immunoelectron microscopy. Am J Pathol 1986;122:17-27.
123. Warfel KA, Benson MD, Hull MD, et al. Pulmonary nodules and pleural plaques in systemic light chain deposition disease. Lab Invest 1987;56:84(abstr).
124. Hoffman-Guilaine C, Nochy D, Tricottet V, et al. La maladie des depots de chaines legeres: une entite ana tomopathologique. Annu PathoI1984;4:105-113.
125. Jacquot C, Saint-Andre Jp, Touchard G, et al. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement. Clin NephroI1985;24:93-98.
126. Linder J, Croker BP, Vollmer RT, et al. Systemic kappa light-chain deposition. An ultrastructural and immunohistochemical study. Am J Surg Pathol 1983;7:85-93.
127. Buxbaum J, Gallo G. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light-and heavy-chain deposition diseases. Hematol Oncol Clin North Am 1999;13:1235-1248.
128. Khoor A, Myers JL, Tazelaar HD, et al. Amyloid-like pulmonary nodules, including localized light-chain deposition: clinicopathologic analysis of three cases. Am J Clin Pathol 2004;121:200-204. 21. Endogenous Mineralization, Inclusions, and Deposition Disorders 801.
129. Engleman P, Liebow AA, Gmelich J, et al. Pulmonary hyalinizing granuloma. Am Rev Respir Dis 1977;115:997-100S.
130. Drasin H, Blume MR, Rosenbaum EH, et al. Pulmonary hyalinizing granulomas in a patient with malignant lymphoma, with development nine years later of multiple myeloma and systemic amyloidosis. Cancer 1979;44:215-220.
131. Guccion JG, Rohatgi PK, Saini N. Pulmonary hyalinizing granuloma. Electron microscopic and immunologic studies. Chest 1984;85:571-573.
132. Schlosnagle DC, Check 11, Sewell CW, et al. Immunologic abnormalities in two patients with pulmonary hyalinizing granuloma. Am J Clin PathoI1982;78:231-235.
133. Chalaoui J, Gregoire P, Sylvestre J, et al. Pulmonary hyalinizing granuloma: a cause of pulmonary nodules. Radiology 1984;152:23-26.
134. Dent RG, Godden DJ, Stovin PG, et al. Pulmonary hyalinising granuloma in association with retroperitoneal fibrosis. Thorax 1983;38:955-956.
135. Macedo EV, Adolph 1. Pulmonary hyalinizing granulomas. J Can Assoc RadioI1985;36:66-67.
136. Maijub AG, Giltman LI, Verner JL, et al. Pulmonary hyalinizing granuloma. Ann Allergy 1985;54:227-229.
137. Ikard RW. Pulmonary hyalinizing granuloma. Chest 1988;93:871-872.
138. Gans SJ, van der Elst AM, Straks w. Pulmonary hyalinizing granuloma. Eur Respir J 1988;1:389-391.
139. Patel Y, Ishikawa S, MacDonnell KF. Pulmonary hyalinizing granuloma presenting as multiple cavitary calcified nodules. Chest 1991;100:1720-1721.
140. Kuramochi S, Kawai T, Yakumaru K, et al. Multiple pulmonary hyalinizing granulomas associated with systemic idiopathic fibrosis. Acta Pathol Jpn 1991;41:375-382.
141. Anazawa Y, Nagai H, Motomiya M, et al. A case of pulmonary hyalinizing granuloma. Tohoku J Exp Med 1992;167: 39-45.
142. Atagi S, Sakatani M, Akira M, et al. Pulmonary hyalinizing granuloma with Castleman's disease. Intern Med 1994;33: 689-691.
143. Pinckard JK, Rosenbluth DB, Patel K, et al. Pulmonary hyalinizing granuloma associated with Aspergillus infection. Int J Surg PathoI2003;11:39-42.
144. Shinohara T, Kaneko T, Miyazawa N, et al. Pulmonary hyalinizing granuloma with laryngeal and subcutaneous involvement: report of a case successfully treated with glucocorticoids. Intern Med 2004;43:69-73.
145. Yousem SA, Hochholzer L. Pulmonary hyalinizing granuloma. Am J Clin PathoI1987;87:1-6.
146. Schmidt RMD. Personal communication, University School of Medicine, Seattle, Washington, 1991.
147. Ren Y, Raitz EN, Lee KR, et al. Pulmonary smalllymphocytic lymphoma (mucosa-associated lymphoid tissue type) associated with pulmonary hyalinizing granuloma. Chest 2001;120:1027-1030.
148. Katzenstein AL, Mazur MT. Pulmonary infarct: an unusual manifestation of fibrosing mediastinitis. Chest 1980;77: 521-524.
149. Goodwin RA, Nickell JA, Des Prez RM. Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore) 1972;51:227-246.
150. Schowengerdt CG, Suyemoto R, Main FB. Granulomatous and fibrous mediastinitis. A review and analysis of 180 cases. J Thorac Cardiovasc Surg 1969;57:365-379.
151. Ulbright TM, Katzenstein AL. Solitary necrotizing granulomas of the lung: differentiating feature and etiology. Am J Surg Pathol 1980;4:13-28.
152. Gorini M, Forloni F, Pezzoli A, et al. Pulmonary hyalinizing granuloma. A limited form of Wegener's granulomatosis? Ann Ital Med Int 1998;13:176-179.
153. Soergel KH, Sommers Sc. The alveolar epithelial lesion of idiopathic pulmonary hemosiderosis. Am Rev Respir Dis 1962;85:540-552.
154. Dail DH, Leibow AA, Gmelich J, et al. A study of 43 cases of pulmonary veno-occlusive (PVO) disease. (Abstract). Lab Invest 1978;340-341.
155. Pai U, McMahon J, Tomashefski JF, Jr. Mineralizing pulmonary elastosis in chronic cardiac failure. "Endogenous pneumoconiosis" revisited. Am J Clin Pathol 1994;101: 22-28.
156. Walton KW, Heath D. Iron incrustation of the pulmonary vessels in patent ductus arteriosus with congenital mitral disease. Br Heart J 1960;22:440-44.
157. Heath D, Smith P. Plexiform lesions with giant cells. Thorax 1982;37:394-395.
158. Kaplan L, Walford RL. Pulmonary fibrosis and giant-cell reaction with altered elastic tissue; endogenous pneumoconiosis. AMA Arch PathoI1957;63:75-90.
159. Chan ED, Morales DV, Welsh CH, et al. Calcium deposition with or without bone formation in the lung. Am J Respir Crit Care Med 2002;165:1654-1669.
160. Virchow R. Kalk-metastasen. Virchows Arch Pathol Anat 1855;8:103-113.
161. Mulligan RM. Metastatic calcification. Arch Pathol 1947;43:177-230.
162. Neff M, Yalcin S, Gupta S, et al. Extensive metastatic calcification of the lung in an azotemic patient. Am J Med 1974;56:103-109.
163. Kuzela DC, Huffer WE, Conger JD, et al. Soft tissue calcification in chronic dialysis patients. Am J Pathol 1977;86: 403-424.
164. Kaltreider HB, Baum GL, Bogaty G, et al. So-called "metastatic" calcification of the lung. Am J Med 1969;46: 188-196.
165. Conger JD, Hammond WS, Alfrey AC, et al. Pulmonary calcification in chronic dialysis patients. Clinical and pathologic studies. Ann Intern Med 1975;83:330-336.
166. Sanders C, Frank MS, Rostand SG, et al. Metastatic calcification of the heart and lungs in end-stage renal disease: detection and quantification by dual-energy digital chest radiography. AJR 1987;149:881-887.
167. Wang NS, Steele AA. Pulmonary calcification: scanning electron microscopic and X-ray energy-dispersive analysis. Arch Pathol Lab Med 1979;103:252-257.
168. Smith JC, Stanton LW, Kramer NC, et al. Nodular pulmonary calcification in renal failure. Report of a case. Am Rev Respir Dis 1969;100:723-728.
169. McLachlan MS, Wallace M, Seneviratne C. Pulmonary calcification in renal failure. Report of three cases. Br J Radiol 1968;41:99-106.
170. Bonin M, Miyai K. Metastatic pulmonary calcification, morphology, chemical and X-ray microanalysis. Lab Invest 1977;36:33l.
171. van der Bij W, Gouw AS, Meinesz AF, et al. Consolidation of both upper lobes. Chest 1991;100:1685-1686.
172. Mootz JR, Sagel SS, Roberts TH. Roentgenographic manifestations of pulmonary calcifications. A rare cause of respiratory failure in chronic renal disease. Radiology 1973;107:55-60.
173. Kuhlman JE, Ren H, Hutchins GM, et al. Fulminant pulmonary calcification complicating renal transplantation: CT demonstration. Radiology 1989;173:459-460.
174. Bloodworth J, Tomashefski JF lr. Localised pulmonary metastatic calcification associated with pulmonary artery obstruction. Thorax 1992;47:174-178.
175. Davidson 1M, Macleod WM. Pulmonary alveolar proteinosis. Br J Dis Chest 1969;63:13-28.
176. Firooznia H, Pudlowski R, Golimbu C, et al. Diffuse interstitial calcification of the lungs in chronic renal failure mimicking pulmonary edema. AJR 1977;129:1103-1105.
177. Koshy MC, Weinstein E, Pope RH, et al. Letter: Calcific cardiomyopathy. N Engl J Med 1975;292:209-210.
178. Boner G, Jacob ET, Pevzner S, et al. Diffuse calcification of lungs in a patient on maintenance hemodialysis. Isr J Med Sci 1971;7:1182-1187.
179. Braude S, Graham A, Mitchell D. Lymphoedema/hypercalcaemia syndrome mediated by parathyroid-hormonerelated protein. Lancet 1991;337:140-141.
180. Felson B. Chest roentgenography. Philadelphia: WB Saunders, 1973:479.
181. Wells HG. Calcification and ossification. Arch Intern Med 1911;7:721-753.
182. Hueper W. Metastatic calcification in the organs of the dog after injection of parathyroid extract. Arch Pathol Lab Med 1927;3:14-25.
183. Lindner A, Charra B, Sherrard DJ, et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
184. Heath D, Robertson AJ. Pulmonary calcinosis. Thorax 1977;32:606-611.
185. Bestetti-Bosisio M, Cotelli F, Schiaffino E, et al. Lung calcification in long-term dialysed patients: a light and electronmicroscopic study. Histopathology 1984;8:69-79.
186. Daust W. Uber verastelte Knochenspangenbidung in der Lung. Frankfurt Z Pat hoi 1929;37:313-327.
187. Salinger H. Die Knochenbildungen in der Lunge mit besonderer Beriicksichtigung der tuberosen Form. Fortschr Geb Rontgenstr 1932;46:269-275.
188. Janker R. Dei verastelten Knockenbildungen in der Lunge. Fortschr Rontgenstr 1936;53:840-860.
189. Wells HG, Dunlap CE. Disseminated ossification of the lungs. Arch Pathol Lab Med 1943;35:420-426.
190. Joines RW, Roggli VL. Dendriform pulmonary ossification. Report of two cases with unique findings. Am J Clin Pathol 1989;91:398-402.
191. Miiller KM, Friemann J, Stichnoth E. Dendriform pulmonary ossification. Pathol Res Pract 1980;168:163-172.
192. Kuplic JB, Higley CS, Niewoehner DE. Pulmonary ossification associated with long-term busulfan therapy in chronic myeloid leukemia. Case report. Am Rev Respir Dis 1972;106:759-762.
193. Ndimbie OK, Williams CR, Lee MW. Dendriform pulmonary ossification. Arch Pathol Lab Med 1987;111: 1062-1064.
194. Wilson WR, Sasaki R, Johnson CA. Disseminated nodular pulmonary ossification in patients with mitral stenosis. Circulation 1959;19:323-331.
195. Pear BL. Idiopathic disseminated pulmonary ossification. Radiology 1968;91:746-748.
196. Epstein EJ, Chapman R, Coulshed N, et al. Pulmonary ossific nodule formation in the absence of mitral valve disease: a report of four cases. Am J Heart 1963;65: 816-825.
197. Galloway RW, Epstein EJ, Coulshed N. Pulmonary ossific nodules in mitral value disease. Br Heart I 1961;23:297-307.
198. Daugavietis HE, Mautner LS. Disseminated nodular pulmonary ossification with mitral stenosis. AMA Arch Pathol 1957;63:7-12.
199. Elkeles A, Glynn LE. Disseminated parenchymatous ossification in the lungs in association with mitral stenosis. J Pat hoi Bacteriol 1946;58:517-522.
200. Popelka CG, Kleinerman J. Diffuse pulmonary ossification. Arch Intern Med 1977;137:523-525.
201. Green JD, Harle TS, Greenberg SD, et al. Disseminated pulmonary ossification. A case report with demonstration of electron-microscopic features. Am Rev Respir Dis 1970;101:293-298.
202. Lendrum AC, Scott LDW, Parks SDS. Pulmonary changes due to cardiac diseases, with special reference to hemosiderosis. Q J Med 1950;19:249-262.
203. Katzenstein A-LA, Askin FB. Surgical pathology of nonneoplastic lung disease. Philadelphia: WB Saunders, 1982: 371.
204. Kuhn C, III, Kuo TT. Cytoplasmic hyalin in asbestosis. A reaction of injured alveolar epithelium. Arch Patho11973;95: 190-194.
205. Phillips MJ. Mallory bodies and the liver. Lab Invest 1982;47:311-313.
206. Warnock ML, Press M, Churg A. Further observations on cytoplasmic hyaline in the lung. Hum Pathol 1980;11: 59-65.
207. Hammar SP. Personal communication. Seattle, Washington, 1986.
208. Denk H, Franke WW, Eckerstorfer R, et al. Formation and involution of Mallory bodies ("alcoholic hyalin") in murine and human liver revealed by immunofluorescence microscopy with antibodies to prekeratin. Proc Nat! Acad Sci 1979;76:4112-4116.
209. Michel RP, Limacher n, Kimoff RJ. Mallory bodies in scar adenocarcinoma of the lung. Hum Pathol 1982;13: 81-85.
210. Dekker A, Krause JR. Hyaline globules in human neoplasms. A report of three autopsy cases. Arch Pathol 1973;95:178-181.
211. Prakash UB, Barham SS, Rosenow EC, III, et al. Pulmonary alveolar microlithiasis. A review including ultrastructural and pulmonary function studies. Mayo Clin Proc 1983;58:290-300.
212. Nolle E, Kaufmann HI Pulmonary alveolar microlithiasis in pediatric patients. A review of the world literature and two new observations. Pediatr RadioI1987;17:439-442.
213. Castellana G, Gentile M, Castellana R, et al. Pulmonary alveolar microlithiasis: clinical features, evolution of the phenotype, and review of the literature. Am J Med Genet 2002;111:220-224.
214. Mariotta S, Ricci A, Papale M, et al. Pulmonary alveolar microlithiasis: report on 576 cases published in the literature. Sarcoidosis Vasc Diffuse Lung Dis 2004;21:173-181.
215. Michaels L, Levene C. Pulmonary corpora amylacea. J Pathol Bacteriol 1957;74:49-56.
216. Harbitz F. Extensive calcification of the lungs as a distinct disease. Arch Intern Med 1918;21:139-146.
217. Puhr L. Mikrolithiasis alveolaris pulmonum. Virchows Arch Pathol Anat 1933;290:156-160.
218. Caffrey PR, Altman RS. Pulmonary alveolar microlithiasis occurring in premature twins. J Pediatr 1965;66:758-763.
219. Thurairajasingam S, Dharmasena BD, Kasthuriratna T. Pulmonary alveolar microlithiasis. Australas Radiol 1975;19:175-180.
220. Thind GS, Bhatia JL. Pulmonary alveolar microlithiasis. Br J Dis Chest 1978;72:151-154.
221. Sosman MC, Dodd GD, Jones WD, et al. The familial occurrence of pulmonary alveolar microlithiasis. Am J Roentgenol Radium Ther Nucl Med 1957;77:947-1012.
222. Castellana G, Lamorgese V. Pulmonary alveolar microlithiasis. World cases and review of the literature. Respiration 2003;70:549-555.
223. Drinkovic I, Strohal K, Sabljica B. Microlithiasis of the pulmonary alveoli. Fortschr Geb Rontgenstr Nuklearmed 1962;97:180-185.
224. Mikhailov V. Klin Med (Mosk) 1954;32:31-36.
225. Jankovic S, Pavlov N, Ivkosic A, et al. Pulmonary alveolar microlithiasis in childhood: clinical and radiological followup. Pediatr Pulmonol 2002;34:384-387.
226. Kino T, Kohara Y, Tsuji S. Pulmonary alveolar microlithiasis. A report of two young sisters. Am Rev Respir Dis 1972;105:105-110.
227. Sears MR, Chang AR, Taylor Al Pulmonary alveolar microlithiasis. Thorax 1971;26:704-711.
228. Puleihan FJD, Abboud RT, Balikian Jp, et al. Pulmonary alveolar microlithiasis: lung function in five cases. Thorax 1969;24:84-90.
229. Biressi PC, Casassa PM. Intraalveolar pulmonary microlithiasis. Minerva Med 1956;47:930-939.
230. Shigeno C, Fukunaga M, Morita R, et al. Bone scintigraphy in pulmonary alveolar microlithiasis: a comparative study of radioactivity and density distribution. Clin Nucl Med 1982;7:103-107.
231. Brown ML, Swee RG, Olson RJ, et al. Pulmonary uptake of 99mTc diphosphonate in alveolar microlithiasis. AJR 1978;131:703-704.
232. Balkian JP, Fuleihan FJD, Nucho CKN. Pulmonary alveolar microlithiasis: report of 5 cases with special reference to roentgen manifestations. AJR 1968;103:509-518.
233. Pant K, Shah A, Mathur RK, et al. Pulmonary alveolar microlithiasis with pleural calcification and nephrolithiasis. Chest 1990;98:245-246.
234. Petit MA. Pulmonary alveolar microlithiasis. Chest 1991;100:290.
235. Cole WR. Pulmonary alveolar microlithiasis. J Fac Radiol 1959;10:54-56.
236. Winzelberg GG, Boller M, Sachs M, et al. CT evaluation of pulmonary alveolar microlithiasis. J Comput Assist Tomogr 1984;8:1029-1031.
237. Korn MA, Schurawitzki H, Klepetko W, et al. Pulmonary alveolar microlithiasis: findings on high-resolution CT. AJR 1992;158:981-982.
238. Chalmers AG, Wyatt J, Robinson PI Computed tomographic and pathological findings in pulmonary alveolar microlithiasis. Br J RadioI1986;59:408-411.
239. Tao LC. Microliths in sputum specimens and their relationship to pulmonary alveolar microlithiasis. Am J Clin Pathol 1978;69:482-485.
240. Palombini BC, da Silva PN, Wallau CU, et al. Bronchopulmonary lavage in alveolar microlithiasis. Chest 1981;80: 242-243.
241. Sharp ME, Danino EA. An unusual form of pulmonary calcification: microlithiasis alveolaris pUlmonum. J Pathol Bacteriol 1953;65:389-399.
242. Kent G, Gilbert ES, Meyer HH. Pulmonary microlithiasis; microlithiasis alveolaris pulmonum. AMA Arch Pathol 1955;60:556-562.
243. Kanat F. Diagnosis of pulmonary alveolar microlithiasis: a comment. Rheumatol Int 2005;25:152-153.
244. Kawakami M, Sato S, Takishima T. Electron microscopic studies on pulmonary alveolar microlithiasis. Tohoku J Exp Med 1978;126:343-361.
245. Bab I, Rosenmann E, Ne'eman Z, et al. The occurrence of extracellular matrix vesicles in pulmonary alveolar microlithiasis. Virchows Arch A Pathol Anat Histol 1981;391: 357-361.
246. Greenberg MI Miliary shadows in the lungs due to microlithiasis alveolaris pulmonum. Thorax 1957;12:171-174.
247. Nouh MS. Is the desert lung syndrome (nonoccupational dust pneumoconiosis) a variant of pulmonary alveolar microlithiasis? Report of 4 cases with review of the literature. Respiration 1989;55:122-126.
248. Edelman JD, Bavaria J, Kaiser LR, et al. Bilateral sequential lung transplantation for pulmonary alveolar microlithiasis. Chest 1997;112:1140-1144.
249. Friedreich N. Kleinere mittheilungen: I. Corpora amylacea in den lungen. Virchows Arch Pathol Anat 1856;9:613-618.
250. Lubarsch 0, Plenge K. Die corpora amylacea. Handb Der Spezielle Pathol Anat U Hist. Vol. 3. Berlin: SpringerVerlag, 1931:607654.
251. Hollander DH, Hutchins GM. Central spherules in pulmonary corpora amylacea. Arch Pathol Lab Med 1978;102: 629-630.
252. Baar HS, Ferguson FF. Microlithiasis alveolaris pUlmonum. Association with diffuse interstitial pulmonary fibrosis. Arch PathoI1963;76:659-666.
253. Steele HD, Kinley G, Leuchtenberger C, et al. Polysaccharide nature of corpora amylacea. AMA Arch Pathol 1952;54:94-97.
254. Dail DH, Liebow AA. Intraalveolar conchoidal bodies. (Abstract). Am J PathoI 11974; 76: 43A.
255. Michaels L. Lung changes in woodworkers. Can Med Assoc J 1967;96:1150-1155.
256. Gardiner IT, Uff JS. "Blue bodies" in a case of cryptogenic fibrosing alveolitis (desquamative type) an ultra-structural study. Thorax 1978;33:806-813.
257. Koss MN, Johnson FB, Hochholzer L. Pulmonary blue bodies. Hum Pathol 1981;12:258-266.
258. Kim CK, Goyal PC, Payne CB Jr. Pulmonary blue bodies. Hum PathoI1983;14:739-740.
259. Kung IT, Johnson FB, So SY, et al. Blue bodies in cytology specimens in a case of pulmonary talcosis. Am J Clin PathoI1984;81:675-678.
260. Williams WI The nature and origin of Schaumann bodies. J Pathol Bacteriol 1960;79:193-201.
261. Williams WJ, Williams D. The properties and development of conchoidal bodies in sarcoid and sarcoid-like granulomas. J Pathol Bacteriol 1968;96:491-496.
262. Pritzker KP, Desai SD, Patterson MC, et al. Calcite sputum lith. Characterization by analytic scanning electron microscopy and X-ray diffraction. Am J Clin Pathol 1981;75: 253-257.
263. Koss MN, Hochholzer L, Feigin DS, et al. Necrotizing sarcoid-like granulomatosis: clinical, pathologic, and immunopathologic findings. Hum Pathol 1980;11:510-519.
264. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958;258:1123-1142.
265. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002;166:215-235.
266. Dirksen U, Hattenhorst U, Schneider P, et al. Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3Iinterleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure. Blood 1998;92:1097-1103.
267. deMello DE, Lin Z. Pulmonary alveolar proteinosis: a review. Pediatr Pathol Mol Med 2001;20:413-432.
268. Presneill JJ, Nakata K, Inoue Y, et al. Pulmonary alveolar proteinosis. Clin Chest Med 2004;25:593-613.
269. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 2003;349:2527-2539.
270. Tazawa R, Hamano E, Arai T, et al. Granulocytemacrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2005;171:1142-1149.
271. Larson RK, Gordinier R. Pulmonary alveolar proteinosis. Report of six cases, review of the literature, and formulation of a new theory. Ann Intern Med 1965;62:292-212.
272. Prakash UB, Barham SS, Carpenter HA, et al. Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc 1987;62:499-518.
273. Kariman K, Kylstra JA, Spock A. Pulmonary alveolar proteinosis: prospective clinical experience in 23 patients for 15 years. Lung 1984;162:223-231.
274. Goldstein LS, Kavuru MS, CurtiS-McCarthy P, et al. Pulmonary alveolar proteinosis: clinical features and outcomes. Chest 1998;114:1357-1362.
275. Asamoto H, Kitaichi M, Nishimura K, et al. Primary pulmonary alveolar proteinosis-clinical observation of 68 patients in Japan. Nihon Kyobu Shikkan Gakkai Zasshi 1995;33:835-845.
276. Rubinstein I, Mullen JB, Hoffstein V. Morphologic diagnosis of idiopathic pulmonary alveolar lipoproteinosisrevisited. Arch Intern Med 1988;148:813-816.
277. Ben Dov I, Kishinevski Y, Roznman J, et al. Pulmonary alveolar proteinosis in Israel: ethnic clustering. Isr Med Assoc J 1999;1:75-78.
278. Mazzone P, Thomassen MJ, Kavuru MS. Pulmonary alveolar proteinosis: recent advances. Semin Respir Crit Care Med 2002;23:115-126.
279. Gough I Silicosis and alveolar proteinosis. Br Med J 1967;1:629.
280. Buechner HA, Ansari A. Acute silico-proteinosis. A new pathologic variant of acute silicosis in sandblasters, characterized by histologic features resembling alveolar proteinosis. Dis Chest 1969;55:274-278.
281. Hoffman EO, Lamberty J, Pizzolato P. The ultrastructure of acute silicosis. Arch Pathol Lab Med 1973;96: 104-107.
282. Xipell JM, Ham KN, Price CG, et al. Acute silicoproteinosis. Thorax 1977;32:104-111.
283. Suratt PM, Winn WC Jr, Brody AR, et al. Acute silicosis in tombstone sandblasters. Am Rev Respir Dis 1977;115: 521-529.
284. Miller RR, Churg AM, Hutcheon M, et al. Pulmonary alveolar proteinosis and aluminum dust exposure. Am Rev Respir Dis 1984;130:312-315.
285. Abraham JL, Auchinclos JH. Pulmonary alveolar proteinosis and kaolin exposure. Am Rev Respir Dis 1985;131: A203(abstr).
286. Gross P, DeTreville RT. Alveolar proteinosis. Its experimental production in rodents. Arch Pathol 1968;86: 255-261.
287. Corrin B, King E. Experimental endogenous lipid pneumonia and silicosis. J PathoI1969;97:325-330.
288. Heppleston AG, Wright NA, Stewart JA. Experimental alveolar lipo-proteinosis following the inhalation of silica. J PathoI1970;101:293-307.
289. Heppleston AG, Young AE. Alveolar lipo-proteinosis: an ultrastructural comparison of the experimental and human forms. J PathoI1972;107:107-117.
290. Martin TR, Wehner AP, Butler I Pulmonary toxicity of Mt. St. Helens volcanic ash. A review of experimental studies. Am Rev Respir Dis 1983;128:158-162.
291. Corrin B, King E. Pathogenesis of experimental pulmonary alveolar proteinosis. Thorax 1970;25:230-236.
292. Gross P, Harley RA Jr, DeTreville RT. Pulmonary reaction to metallic aluminum powders: an experimental study. Arch Environ Health 1973;26:227-236.
293. Schober R, Kosek JC, Bensch KG. Origin of the membranous intraalveolar material in pulmonary alveolar proteinosis. Lab Invest 1974;30:388-389.
294. Likhaechev I, Batsura I, Direev VI. The role of several occupational factors in the development of pulmonary alveolar proteinosis (an experimental study). Arkh Patol 1975;37:63-69.
295. Lakshminarayan S, Schwarz MI, Stanford RE. Unsuspected pulmonary alveolar proteinosis complicating acute myelogenous leukemia. Chest 1976;69:433-435.
296. Bedrossian CW, Luna MA, Conklin RH, et al. Alveolar proteinosis as a consequence of immunosuppression. A hypothesis based on clinical and pathologic observations. Hum Pathol 1980;11:527-535.
297. Doyle AP, Balcerzak SP, Wells CL, et al. Pulmonary alveolar proteinosis with hematologic disorders. Arch Intern Med 1963;112:940-946.
298. Steer A. Focal pulmonary alveolar proteinosis in pulmonary tuberculosis. Arch Pathol 1969;87:347-352.
299. Payseur CR, Konwaler BE, Hyde L. Pulmonary alveolar proteinosis; a progressive, diffuse, fatal pulmonary disease. Am Rev Tuberc 1958;78:906-915.
300. Reyes 1M, Putong PB. Association of pulmonary alveolar lipoproteinosis with mycobacterial infection. Am 1 Clin Pathol 1980;74:478-485.
301. Pascual J, Gomez Aguinaga MA, Vidal R, et al. Alveolar proteinosis and nocardiosis: a patient treated by bronchopulmonary lavage. Postgrad Med J 1989;65:674-677.
302. Ruben FL, Talamo TS. Secondary pulmonary alveolar proteinosis occurring in two patients with acquired immune deficiency syndrome. Am J Med 1986;80:1187-1190.
303. Butnor KJ, Sporn TA. Human parainfluenza virus giant cell pneumonia following cord blood transplant associated with pulmonary alveolar proteinosis. Arch Pathol Lab Med 2003;127:235-238.
304. Tran VN, Vojtek AM, Bernaudin 1F, et al. Pulmonary alveolar proteinosis associated with Pneumocystis carinii. Ultrastructural identification in bronchoalveolar lavage in AIDS and immunocompromised non-AIDS patients. Chest 1990;98:801-805.
305. Gal AA, Bryan JA, Kanter KR, et al. Cytopathology of pulmonary alveolar proteinosis complicating lung transplantation. J Heart Lung Transplant 2004;23:135-138.
306. Yousem SA. Alveolar lipoproteinosis in lung allograft recipients. Hum PathoI1997;28:1383-1386.
307. 10hkoh T, Itoh H, Muller NL, et al. Crazy-paving appearance at thin-section CT: spectrum of disease and pathologic findings. Radiology 1999;211:155-160.
308. Maygarden Sl, Iacocca MV, Funkhouser WK, et al. Pulmonary alveolar proteinosis: a spectrum of cytologic, histochemical, and ultrastructural findings in bronchoalveolar lavage fluid. Diagn Cytopathol 2001;24:389-395.
309. Corsello BF, Choi H. Basophilic staining in pulmonary alveolar proteinosis. Report of three cases. Arch Pathol Lab Med 1984;108:68-70.
310. Singh G, Katyal SL, Bedrossian CW, et al. Pulmonary alveolar proteinosis. Staining for surfactant apoprotein in alveolar proteinosis and in conditions simulating it. Chest 1983;83:82-86.
311. Colon AR Jr, Lawrence RD, Mills SD, et al. Childhood pulmonary alveolar proteinosis (PAP). Report of a case and review of the literature. Am 1 Dis Child 1971;121: 481-485.
312. William GE. Pulmonary alveolar proteinosis. Lancet 1960;1385-1388.
313. Sieracki JC, Horn RC Jr, Kay S. Pulmonary alveolar proteinosis: report of three cases. Ann Intern Med 1959;51: 728-739.
314. Singh G, Katyal SL. Surfactant apoprotein in nonmalignant pulmonary disorders. Am J PathoI1980;101:51-62.
315. Bjorkholm B, Elgefors B. Cerebellar aspergilloma. Scand 1 Infect Dis 1986;18:375-378.
316. Fried J, Hinthorn D, Ralstin J, et al. Cure of brain abscess caused by Nocardia asteroides resistant to multiple antibiotics. South Med J 1988;81:412-413.
317. Abdul Rahman JA, Moodley YP, Phillips M1. Pulmonary alveolar proteinosis associated with psoriasis and complicated by mycobacterial infection: successful treatment with granulocyte-macrophage colony stimulating factor after a partial response to whole lung lavage. Respirology 2004;9:419-422.
318. Goldschmidt N, Nusair S, Gural A, et al. Disseminated Mycobacterium kansasii infection with pulmonary alveolar proteinosis in a patient with chronic myelogenous leukemia. Am J HematoI2003;74:221-223.
319. Burbank B, Morrione TG, Cutler SS. Pulmonary alveolar proteinosis and nocardiosis. Am J Med 1960;28:1002-1007.
320. Carlsen ET, Hill RB Jr, Rowlands DT 1r. Nocardiosis and pulmonary alveolar proteinosis. Ann Intern Med 1964;60: 275-281.
321. Ramirez J, Savard EV, Hawkins JE. Biological effect of pulmonary washings from cases of alveolar proteinosis. Am Rev Respir Dis 1966;94:244-246.
322. Golde DW, Territo M, Finley TN, et al. Defective lung macrophages in pulmonary alveolar proteinosis. Ann Intern Med 1976;85:304-309.
323. Harris Jo. Pulmonary alveolar proteinosis: abnormal in vitro function of alveolar macrophages. Chest 1979;76:156-159.
324. Kuhn C, Gyorkey F, Levine BE, et al. Pulmonary alveolar protein os is. A study using enzyme histochemistry, electron microscopy, and surface tension measurement. Lab Invest 1966;15:492-509.
325. Basset F, Soler P, Turiaf 1. Etude ultra structurale du contenu alveolar dans la proteinose alveolaire pulmonaire et dans les pseudoproteinoses. Am Med Interne (Paris) 1973;24: 279-290.
326. Costello 1F, Moriarty DC, Branthwaite MA, et al. Diagnosis and management of alveolar proteinosis: the role of electron microscopy. Thorax 1975;30:121-132.
327. Ramirez J, Harlan WR Jr. Pulmonary alveolar proteinosis, nature and origin of alveolar lipid. Am J Med 1968;45: 502-512.
328. McClenahan JB. Pulmonary alveolar proteinosis. Arch Intern Med 1974;133:284-287.
329. Alberti A, Luisetti M, Braschi A, et al. Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage. Am J Respir Crit Care Med 1996;154:817-820.
330. Doyle IR, Davidson KG, Barr HA, et al. Quantity and structure of surfactant proteins vary among patients with alveolar proteinosis. Am J Respir Crit Care Med 1998;157:658-664.
331. Honda Y, Takahashi H, Shijubo N, et al. Surfactant proteinA concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Chest 1993;103:496-499.
332. Crouch E, Persson A, Chang D. Accumulation of surfactant protein D in human pulmonary alveolar proteinosis. Am J PathoI1993;142:241-248.
333. Honda Y, Kuroki Y, Matsuura E, et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med 1995;152:1860-1866.
334. Brasch F, Birzele J, Ochs M, et al. Surfactant proteins in pulmonary alveolar proteinosis in adults. Eur Respir J 2004;24:426-435.
335. Whitsett JA, Weaver TE. Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 2002;347:2141-2148.
336. Trapnell BC, Whitsett JA. Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol 2002;64:775-802.
337. Stanley E, Lieschke GJ, Grail D, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Nat! Acad Sci 1994;91:5592-5596.
338. Thomassen MJ, Yi T, Raychaudhuri B, et al. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Clin Immunol 2000;95:85-92.
339. Bonfield TL, Russell D, Burgess S, et al. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Bioi 2002;27:481-486.
340. Uchida K, Nakata K, Trapnell BC, et al. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis. Blood 2004;103:1089-1098.
341. Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999;190:875-880.
342. Ramirez 1. Bronchopulmonary lavage. New techniques and observations. Dis Chest 1966;50:581-588.
343. Ramirez 1. Alveolar proteinosis: importance of pulmonary lavage. Am Rev Respir Dis 1971;103:666-678.
344. Cordonnier C, Fleury-Feith J, Escudier E, et al. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med 1994;149:788-794.
345. Kavuru MS, Sullivan EJ, Piccin R, et al. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000;161:1143-1148.
346. Knight DP, Knight JA. Pulmonary alveolar proteinosis in the newborn. Arch Pathol Lab Med 1985;109:529-531.